Cargando…

重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348515/
https://www.ncbi.nlm.nih.gov/pubmed/27995889
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.11.015
_version_ 1783556844371836928
collection PubMed
description
format Online
Article
Text
id pubmed-7348515
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73485152020-07-16 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2016-11 /pmc/articles/PMC7348515/ /pubmed/27995889 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.11.015 Text en 2016年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title_full 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title_fullStr 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title_full_unstemmed 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title_short 重型再生障碍性贫血异基因造血干细胞移植后EBV相关淋巴细胞增殖性疾病五例报告及文献复习
title_sort 重型再生障碍性贫血异基因造血干细胞移植后ebv相关淋巴细胞增殖性疾病五例报告及文献复习
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348515/
https://www.ncbi.nlm.nih.gov/pubmed/27995889
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.11.015
work_keys_str_mv AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí
AT zhòngxíngzàishēngzhàngàixìngpínxuèyìjīyīnzàoxuègànxìbāoyízhíhòuebvxiāngguānlínbāxìbāozēngzhíxìngjíbìngwǔlìbàogàojíwénxiànfùxí